Christoph Wyen

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Pilar Mendoza, Henning Gruell, Lilian Nogueira et al. · Nature · 2018 · 523 citations

Human Retrovirus, Immunology, Antiviral Therapy +6

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Marina Caskey, Till Schoofs, Henning Gruell et al. · Nature Medicine · 2017 · 491 citations

Hiv-1-infected Individuals, Human Retrovirus, Immunology +7

Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients

Christian Hoffmann, Tanya Welz, Michael Sabranski et al. · HIV Medicine · 2016 · 272 citations · Full text

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study

Jean van Wyk, Faïza Ajana, Fiona Bisshop et al. · Clinical Infectious Diseases · 2020 · 257 citations · Full text

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

Yotam Bar‐On, Henning Gruell, Till Schoofs et al. · Nature Medicine · 2018 · 247 citations

Viremic Individuals, Antiviral Activity, Human Retrovirus +10